Positron emission tomography (PET)-based imaging may offer a promising alternative to conventional imaging for characterizing the true extent of disease in men who experience early biochemical recurrence following primary treatment for prostate cancer (PCa), according to a new systematic review and meta-analysis published in the World Journal of Urology. {read more here}